Guidelines for the prevention of intravascular catheter-related infections.

By N. O’grady, M. Alexander, E. Dellinger, J. Gerberding, Stephen O. Heard, Dennis G. Maki, H. Masur, R. D. Mccormick, L. A. Mermel, Michele L. Pearson and 13 more. Infection control and hospital epidemiology, 2002

2,111 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/845d5b2e7333f6f7d04084fe2f69d83405ca7292

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Arends
2. L. Pironi
3. F. Bozzetti
4. M. Tomblyn
5. T. Chiller
6. R. Gress
7. C. Cuerda
8. K. Sepkowitz

Citations in the corpus

• Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplant Recipients: A Global Perspective (2009, background): “For HCT centers with high CLABSI rates (more than 1 per 1000 catheter days) despite effective implementation of the CLABSI bundle elements, use of additional interventions, such as minocycline/rifampin antimicrobial-impregnated catheters, to prevent CLABSIs should be considered (BIII) [182] .”
• ESPEN guidelines on chronic intestinal failure in adults. (2016, background): “The literature indicates that infections are more common when CVCs with more lumens than absolutely necessary are used [440,441].”
• epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England (2007, methodology): “334 Long-term tunnelled CVCs are frequently used for patients with cancer who require intravenous treatments.”
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, unknown): “Details on appropriate methods to draw and transport blood culture samples are enumerated in other guidelines [61, 62].”